Blauvelt,  10/10/2019

Solution debuts at CPhI Worldwide, Nov 5-7 in Frankfurt, Hall 11.1, Booth C45

Schreiner MediPharm Introduces New Tamper-Evident Flexi-Cap Prime for Vials

Due to its combined tear strip for the label and cap, the new Flexi-Cap Prime offers even higher safety.

Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, has developed a new label-cap combination that protects the integrity of original medicine containers, helping to prevent illegal reuse through clear, irreversible first-opening indication. At CPhI Worldwide in Frankfurt, November 5-7, the company will present Flexi-Cap Prime, the latest addition to its Flexi-Cap portfolio of security solutions offering even higher degrees of safety.

Empty medicine containers with original labels can be filled with ineffective or harmful substitutes and reintroduced into the market by counterfeiters, posing risks to patients and challenges to pharmaceutical manufacturers.

To help counteract this, a special feature of Flexi-Cap Prime is its complex construction, including a tear strip running through both the film cap and the label. When the tear strip is opened at the starter tab, it simultaneously destroys the cap and the label so that undetected reuse of the container is no longer possible.

Like all products in the Flexi-Cap family, Flexi-Cap Prime can easily be integrated into a pharmaceutical manufacturer’s production processes. It is also applied without heat, and can be flexibly adapted to diverse container types, shapes and sizes while the label’s design and the pharma manufacturer’s brand appearance remain unchanged. The integration of additional features, such as counterfeiting protection elements, offers further opportunities for securing the supply chain.

For healthcare staff, the newly developed Flexi-Cap Prime is ideal, too: It ensures the integrity of the vial until its final application. Flexi-Cap Prime is easy to use and enables fast and efficient first-opening verification. Thus, patients can be protected against the administration of ineffective and potentially harmful medications.

Other highlights at Schreiner MediPharm’s booth (Hall 11.1, Booth C45) include Cap-Lock, the novel combination of a tamper-proof cap adapter plus label for syringes, and smart labels with integrated NFC/RIFD functionality for a wide range of interactive applications.
 

For further information, contact:
Schreiner MediPharm, a business unit of
Schreiner Group LP
300 Corporate Drive, Suite 10
Blauvelt, NY 10913
Phone (845) 848-9000
Fax  (845) 848-9041
info@schreiner-medipharm.com 
www.schreiner-medipharm.com